Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 4Gynecologic 3Gastrointestinal 3Dermatologic 3Other hematologic neoplasm 2Genitourinary 2Breast 2Other 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Radiodermatitis 1Eczema 1Dyspareunia 1Dermatitis 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Laser Therapy × Breast × Clear all
NCT03307044 2023-03-20

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Ohio State University Comprehensive Cancer Center

Phase NA Completed
66 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Dyspareunia

NCT02003599 2018-05-14

Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy

Universidade do Vale do Sapucai

Phase NA Completed
52 enrolled
Breast

Breast Neoplasms, Dermatitis, Eczema, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡